ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors

Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological, genetic, and epigenetic levels. Exome sequencing has identified ARID1A as a novel tumor suppressor gene coding for a chromatin remodeling protein that is mutated in UBC. Here, we assess ARID1A alterations in two series o...

Descripción completa

Detalles Bibliográficos
Autores principales: Balbás-Martínez, Cristina, Rodríguez-Pinilla, María, Casanova, Ariel, Domínguez, Orlando, Pisano, David G., Gómez, Gonzalo, Lloreta, Josep, Lorente, José A., Malats, Núria, Real, Francisco X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641081/
https://www.ncbi.nlm.nih.gov/pubmed/23650517
http://dx.doi.org/10.1371/journal.pone.0062483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641081/
https://www.ncbi.nlm.nih.gov/pubmed/23650517
http://dx.doi.org/10.1371/journal.pone.0062483

Ejemplares similares